STOCKHOLM, Oct. 24, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) founder Lars Lannfelt will be presented with the Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research at the Clinical Trials for Alzheimer's Disease Conference (CTAD) held in...
Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD
Seaking AlphaSeeking Alpha / Seaking Alpha 3 hours ago 1 Views
Comments